封面
市場調查報告書
商品編碼
1425169

關節重組設備市場 - 2024 年至 2029 年預測

Joint Reconstruction Devices Market - Forecasts from 2024 to 2029

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計聯合重組設備市場在預測期內將以 4.53% 的複合年成長率成長。

關節重建手術是一種旨在緩解關節炎和關節損傷的外科手術。在該手術中,受損的關節被移除並替代為由金屬、塑膠或陶瓷材料製成的人工關節。人工關節旨在模仿健康關節的自然運動。全關節重建中使用的器械具有多種功能,包括更換或替代關節表面、提供初步固定以及作為關節關節重建過程中不可或缺的一部分。此外,輔助醫療設備也屬於這一類。這包括特定的關節部位,例如髖關節的球和/或窩、股骨的兩個髁、脛骨和/或膝蓋骨的相應表面、股骨的轉子槽、以及球和/或骨節。肩關節窩。包括要更換的設備。

市場促進因素

  • 不斷發展的技術

在全球範圍內,多項創新技術改變了關節重建手術的格局。機器人、電腦導航、3D 列印植入、智慧感測器、穿戴式裝置和擴增實境等創新正在對該領域產生重大影響。例如,電腦導航使用專用的軟體和感測器來創建患者膝關節或髖關節的術前 3D 模型。先進的影像技術,包括 X 光、MRI 和新的 3D動態捕捉技術,在術前、術中和術後評估中發揮著至關重要的作用。

擴增實境技術是一項顯著的進步,它使外科醫生能夠可視化患者膝蓋的解剖結構,並透過在手術區域疊加影像來即時追蹤手術進展。

「智慧」植入和穿戴式技術的整合改變了手術恢復方式,並促進了患者、外科醫生和物理治療師之間的積極合作。這些創新正在徹底改變關節關節重建手術的方法,提高整個過程的精確度、即時監控和患者參與度。

  • 老年人口增加

在全球範圍內,關節重組設備市場受到人口變化的顯著影響。 2016年,亞太地區約12.4%的人口年齡在60歲以上,但預計到2050年這一數字將增加到四分之一以上,即13億人。在此背景下,醫療保健需求的上升值得關注。然而,在東亞和北亞(包括日本和韓國等人口老化嚴重的國家),預計到2050年將有超過三分之一的人口年齡在60歲以上,而且這種情況因地區而異。

在歐盟(EU),關節重組器械市場也受到人口老化的影響。歐盟27國的老年人口(此處定義為65歲以上人口)將大幅成長,從2019年初的9,050萬增加到2050年的1.298億。在此期間,歐盟27國75-84歲人口預計將增加56.1%,65-74歲人口將增加16.6%。

在關節重組器材市場和醫療保健的背景下,值得注意的是,在全球範圍內,低度開發地區的老年人口成長速度快於已開發地區。因此,老年人將越來越集中在低度開發地區。我們強調醫療保健和相關技術(包括關節重組設備)日益重要。

市場挑戰

  • 設備和流程高成本

與關節重組設備和手術相關的高成本對患者和醫療保健系統都構成了重大挑戰。有幾個因素造成了這種經濟負擔。首先,關節重組裝置很複雜,通常由鈦或鈷鉻等高級材料製成,製造成本昂貴。製造過程需要專門的設備和專業知識,進一步推高了成本。

此外,聯合重組的綜合性質涉及各種相關成本,而不僅僅是儀器本身。術後護理、外科醫師費用、住院費用等都會造成整體經濟負擔。這些成本是聯合重組過程的一個組成部分,也增加了挑戰。

然而,隨著新技術的發展和競爭性市場策略的出現,形勢正在改變。這些進步也正在逐步改善聯合重組領域的產品,也可能減少與共同重組相關的成本挑戰。

依關節類型,關節重組器材市場分為膝關節、髖關節、肩關節、踝關節等。

在關節重組市場中,有許多按關節類型分類的需求。它主要是由技術進步所驅動的。膝關節重組由最尖端科技驅動,包括植入膝關節相關疾病植入的全膝關節置換術(TKR)和部分膝關節置換術(PKR) 。),我們提供量身定做的解決方案。髖關節重組透過全髖關節置換術術 (THR) 和使用股骨柄、髀臼杯和股骨頭等先進植入進行髖關節表面置換術等手術來解決髖關節問題。

亞太地區(APAC)預計將佔據關節重組設備市場的主要佔有率。

由於經濟開拓和醫療保健支出的增加,預計亞太地區(APAC)將在關節重組設備市場中發揮重要作用。 2010年至2018年,亞太地區經濟體的實質醫療支出佔人均GDP的比例年平均成長6.4%。對這一成長做出貢獻的著名國家包括中國、東帝汶和土庫曼斯坦,這些國家的人均醫療支出相對於人均國內生產總值的比例迅速成長。醫療保健支出的這些趨勢可能會改變醫療保健格局,特別是影響市場形勢的發展。

公司產品

  • NewtonTM 平衡膝關節系統:NewtonTM 平衡膝關節系統採用即時、可量化的軟組織資料,並作為類似 GPS 的工具執行針對患者的特定計劃。使用牛頓通訊協定,外科醫生可以獲得全方位的綜合軟組織分析,並能夠在開始切除之前預測術後穩定性。該系統透過簡化的手術技術確保再現性並提供一致的結果。 NewtonTM 系統憑藉經過驗證的 ±0.6mm 精度和準確度以及取得專利的無影像 GPS 主動追蹤技術,提供可靠的性能。它以其實用效率而著稱,其緊湊的設計適合門診手術中心 (ASC),從而降低了資本成本和年度維護成本。
  • 膝關節關節重建產品:Zimmer Biomet 提供全面的膝關節關節重建產品,為外科醫生的各種膝關節關節重建手術提供了多種選擇。產品範圍包括全膝關節置換術系統、部分膝關節置換術系統、雙側膝關節保留系統和膝關節重新置換系統。這些系統允許外科醫生在每次手術中採取針對患者的具體方法。全附件系統優先考慮膝關節的自然運動,並根據個人解剖結構(包括初級附件系統)為膝關節重組提供廣泛的植入選擇。此外,Zimmer Biomet 透過膝關節重新置換系統提供固定、約束、軟組織和骨缺損管理解決方案,以解決膝關節重新置換術中面臨的挑戰。
  • 髖關節植入(Stryker):在髖關節植入領域,我們為全髖關節置換術提供全面的產品系列,涵蓋初次和重新置換產品組合。這些帶有 SOMA 印記的產品系列經過精心設計,以確保最佳的貼合性和功能。 SOMA 的產品組合包括各種植入、設備和手術選擇,特別強調置換術。這項承諾延伸到保持在最新進展的前沿,包括採用 Mako 全髖關節置換術術等創新方法。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 先決條件

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章關節重組設備市場:依技術分類

  • 介紹
  • 關節重建
  • 截骨術
  • 關節鏡
  • 重鋪
  • 其他

第6章關節重組器材市場:依關節類型

  • 介紹
  • 膝蓋
  • 腰部
  • 肩膀
  • 其他

第7章聯合重組儀器市場:依最終使用者分類

  • 介紹
  • 醫院
  • 診所
  • 其他

第8章聯合重組設備市場:按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 泰國

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作

第10章 公司簡介

  • Stryker
  • Drager
  • Exactech
  • Just Medical Devices(Tianjin)Co. Ltd.
  • Smith & Nephew
  • TTK Healthcare
  • JRI Orthopaedics
  • Zimmer Biomet
  • Meril Life
  • DSM Biomedical
簡介目錄
Product Code: KSI061616259

The joint reconstruction devices market is estimated to grow at a CAGR of 4.53% during the forecast period.

Joint replacement is a surgical intervention aimed at alleviating arthritis or damage in a joint. During this procedure, damaged joints are excised and substituted with a prosthesis crafted from metal, plastic, or ceramic materials. The prosthesis is designed to emulate the natural movement of a healthy joint. Devices used in joint replacement serve various functions, such as replacing or substituting the joint's articulating surface, providing primary fixation, and serving as intrinsic elements integral to the joint replacement process. Additionally, ancillary medical devices are also part of this category. This encompasses devices that replace specific joint parts, such as the ball and/or socket in the hip, the two condyles of the femur, and corresponding surfaces of the tibia and/or patella, or trochlear groove of the femur, and the ball and/or socket in the shoulder.

Market Drivers

  • Evolving technology

Globally, several transformative technologies have revolutionized the landscape of joint replacement surgeries. Innovations such as robotics, computer navigation, 3D printed implants, smart sensors, wearables, and augmented reality have significantly impacted the field. Technologies such as, computer navigation utilizes specialized software and sensors to create a pre-surgery 3D model of a patient's knee or hip joint. Advanced imaging techniques, including X-ray, MRI, and emerging 3D motion capture technology, play pivotal roles in pre-, intra, and post-operative assessments.

Augmented reality technology is a noteworthy advancement, allowing surgeons to visualize a patient's knee structures and track surgical progress in real-time by overlaying images onto the surgical field.

The integration of "smart" implants and wearable technology has transformed surgical recovery and fostered active collaboration between patients, surgeons, and physical therapists. These innovations mark a significant shift in the approach to joint replacement surgeries, enhancing precision, real-time monitoring, and patient engagement throughout the entire process.

  • Growing geriatric population

Globally, the joint reconstruction devices market is significantly impacted by the demographic shift. In 2016, approximately 12.4% of the population in the region of APAC was 60 years or older, but this is projected to increase to more than a quarter - or 1.3 billion- people by 2050. The growing healthcare needs in this context are notable. There are, however, variations across the region in East and North Asia (which includes countries with significant aging populations such as Japan and the Republic of Korea), over a third of the population is expected to be 60 years or older by 2050.

In the European Union, the joint reconstruction devices market is also influenced by the aging population. The population of older people (defined here as those aged 65 years or more) in the EU-27 will increase significantly, rising from 90.5 million at the start of 2019 to 129.8 million by 2050. During this period, the number of people in the EU-27 aged 75-84 years is projected to expand by 56.1%, while the number aged 65-74 years is projected to increase by 16.6%.

In the context of the joint reconstruction devices market and healthcare, it is noteworthy that globally, the older population in less developed regions is growing faster than in the more developed regions. Therefore, older persons will be increasingly concentrated in the less developed regions of the world. Emphasizing the growing importance of healthcare and associated technologies, including joint reconstruction devices.

Market Challenges

  • High cost of devices and procedures

The high cost associated with joint reconstruction devices and procedures poses a significant challenge for both patients and healthcare systems. Several factors contribute to this financial burden. Firstly, the intricacy of joint reconstruction devices, frequently crafted with high-grade materials such as titanium and cobalt chrome, leads to elevated production expenses. The manufacturing process necessitates specialized equipment and expertise, further driving up costs.

Additionally, the comprehensive nature of joint reconstruction involves not only the device itself but also various associated expenses. Post-operative care, surgeon fees, and hospital charges collectively contribute to the overall financial burden. These costs are integral components of the joint reconstruction process, adding to the challenges.

Nevertheless, the landscape is evolving with the advent of new technological developments and competitive marketing strategies. These advancements are gradually leading to improved offerings in the field of joint reconstruction, potentially mitigating some of the cost challenges associated with these procedures.

By joint type, the joint reconstruction devices market is divided into knee, hip, shoulder, ankle, and others

In the joint reconstruction market, categorization by joint type has multiple needs. It is primarily propelled by advancements in technology. Knee joint reconstruction, driven by cutting-edge technologies, offers tailored solutions for knee-related conditions, including total knee replacement (TKR) or partial knee replacement (PKR) with advanced femoral and tibial implants. Hip joint reconstruction tackles hip issues through procedures like total hip replacement (THR) and hip resurfacing, with advanced implants such as femoral stems, acetabular cups, and femoral heads.

APAC is anticipated to hold a significant share of the joint reconstruction devices market.

The Asia-Pacific (APAC) region is going to play a significant role in the joint reconstruction devices market, driven by economic development and increased healthcare expenditure. From 2010 to 2018, the APAC economies experienced an average annual growth of 6.4% in real health expenditure as a percentage of GDP per capita. Noteworthy contributors to this growth include China, Timor-Leste, and Turkmenistan, showcasing rapid increases in health expenditure per capita compared to GDP per capita. This trend in healthcare spending is set to change the healthcare landscape, particularly impacting advancements in the joint reconstruction devices market.

Market Developments

  • March 2023 - Stryker introduced the exclusive FDA-cleared hydrocarbon-bearing material choice for shoulder hemiarthroplasty. The inaugural procedure in the United States following the De Novo clearance utilized the Tornier Pyrocarbon Humeral Head, marking a significant milestone. Stryker's De Novo request, granted in late 2022, came after the successful completion of an Investigational Device Exemption (IDE) study in collaboration with the FDA.
  • March 2021 - Smith+Nephew, the global medical technology company, unveiled its newest Sports Medicine advancements for joint repair and arthroscopic enabling technologies at the American Academy of Orthopaedic Surgeons 2022 Annual Meeting in Chicago, IL. The cutting-edge technologies showcased will encompass the FAST-FIX FLEX Meniscal Repair System, INTELLIO Connected Tower, WEREWOLF FASTSEAL 6.0 Hemostasis Wand, REGENETEN Bioinductive Implant, and CAP-FIX◊ Suture Passer.
  • August 2021 - Zimmer Biomet and Canary Medical received FDA De Novo classification and approval to market the world's first and only Smart Knee Implant. The FDA granted authorization for the tibial extension component of Persona IQ®, a groundbreaking smart knee designed for total knee replacement surgery. Persona IQ® integrates Zimmer Biomet's established knee implant, Persona® The Personalized Knee®, with Canary Medical's exclusive implantable sensor technology called canturioTMte tibial extension. This technology measures and assesses various gait metrics, including range of motion, step count, and walking speed, marking a significant advancement in knee replacement surgery.

Company Products

  • NewtonTM Balanced Knee System - The NewtonTM Balanced Knee System employs real-time quantifiable soft tissue data, acting as a GPS-like tool for executing patient-specific plans. Utilizing the Newton protocol, surgeons can access comprehensive soft tissue analytics across the full range, predicting postoperative stability before initiating any resections. The system ensures reproducibility through a streamlined and simplified surgical technique, leading to consistent outcomes. With a proven ± .6mm accuracy and precision, and patented image-free GPS active tracking technology, the NewtonTM system offers reliable performance. Notably, its practical efficiency is highlighted by its compact, ambulatory surgery center (ASC)-friendly design, alleviating the burden of capital costs and annual maintenance fees.
  • Knee Replacement Products - Zimmer Biomet presents a comprehensive range of Knee Replacement Products, providing surgeons with versatile options for various knee replacement procedures. The offerings include Total Knee Systems, Partial Knee Systems, Bicruciate Preserving Arthroplasty Systems, and Revision Knee Systems. These empower surgeons to adopt a patient-specific approach for each procedure. The Total Knee Systems prioritize natural knee motion, offering extensive implant options for reconstructing the knee based on individual anatomy-covering Primary Knee Systems. Additionally, Zimmer Biomet addresses challenges encountered in revision knee arthroplasty, providing solutions for fixation, constraint, soft tissue, and bony defect management within Revision Knee Systems.
  • Hip Implants (Stryker) - In the realm of hip implants, they offer a comprehensive range for total hip arthroplasty, encompassing primary and revision portfolios. These portfolios are meticulously designed, bearing the SOMA imprint, ensuring optimal fit and function. Their offerings include a diverse array of implants, instrumentation, and surgical approach options, with a particular emphasis on novel muscle-sparing techniques for total hip arthroplasty. The commitment extends to staying at the forefront of the latest advancements, including the adoption of innovative approaches like Mako Total Hip Replacement.

Market Segmentation

By Technique

  • Joint Replacement
  • Osteotomy
  • Arthroscopy
  • Resurfacing
  • Others

By Joint Type

  • Knee
  • Hip
  • Shoulder
  • Ankle
  • Others

By End-user

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. JOINT RECONSTRUCTION DEVICES MARKET BY TECHNIQUE

  • 5.1. Introduction
  • 5.2. Joint Replacement
  • 5.3. Osteotomy
  • 5.4. Arthroscopy
  • 5.5. Resurfacing
  • 5.6. Others

6. JOINT RECONSTRUCTION DEVICES MARKET BY JOINT TYPE

  • 6.1. Introduction
  • 6.2. Knee
  • 6.3. Hip
  • 6.4. Shoulder
  • 6.5. Ankle
  • 6.6. Others

7. JOINT RECONSTRUCTION DEVICES MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Others

8. JOINT RECONSTRUCTION DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. Stryker
  • 10.2. Drager
  • 10.3. Exactech
  • 10.4. Just Medical Devices (Tianjin) Co. Ltd.
  • 10.5. Smith & Nephew
  • 10.6. TTK Healthcare
  • 10.7. JRI Orthopaedics
  • 10.8. Zimmer Biomet
  • 10.9. Meril Life
  • 10.10. DSM Biomedical